3rd Quarter - Report

AMERICAN ASSOCIATION FOR CANCER RESEARCH for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts. OMB proposed rule on revisions to the Uniform Guidance.

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

Tobacco control and prevention Tobacco cessation

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Reducing cancer disparities Cancer survivorship

LobbyistCovered position, as disclosed
MATTHEW GONTARCHICK —
CARLY MCCALLIE —
BLAKE WILLIAM ROSTINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.